Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
Authors:
Open Access
- 29 September 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (10) , 1631-1640
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018JAMA Network Open, 2022
- Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza VaccineThe Journal of Infectious Diseases, 2021
- Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017–2020Clinical Infectious Diseases, 2021
- A Real-World Analysis of Patient Characteristics and Predictors of Hospitalization Among US Medicare Beneficiaries with Respiratory Syncytial Virus InfectionAdvances in Therapy, 2020
- Respiratory syncytial virus infection in adultsBMJ, 2019
- The burden of respiratory infections among older adults in long-term care: a systematic reviewBMC Geriatrics, 2019
- Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired PneumoniaJournal of Clinical Microbiology, 2017
- Estimates of mortality attributable to influenza and RSV in the United States during 1997–2009 by influenza type or subtype, age, cause of death, and risk statusInfluenza and Other Respiratory Viruses, 2014
- Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical OutcomesClinical Infectious Diseases, 2013
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003